Simulations Plus/$SLP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Simulations Plus
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Ticker
$SLP
Sector
Primary listing
Employees
245
Headquarters
Website
Simulations Plus Metrics
BasicAdvanced
$310M
-
-$3.15
0.85
-
Price and volume
Market cap
$310M
Beta
0.85
52-week high
$37.67
52-week low
$12.39
Average daily volume
613K
Financial strength
Current ratio
5.111
Quick ratio
4.682
Long term debt to equity
0.364
Total debt to equity
0.581
Profitability
EBITDA (TTM)
13.045
Gross margin (TTM)
53.75%
Net profit margin (TTM)
-78.62%
Operating margin (TTM)
9.06%
Effective tax rate (TTM)
8.95%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
2.74%
Return on equity (TTM)
-41.49%
Valuation
Price to revenue (TTM)
3.846
Price to book
2.5
Price to tangible book (TTM)
6.18
Price to free cash flow (TTM)
29.312
Free cash flow yield (TTM)
3.41%
Free cash flow per share (TTM)
0.525
Growth
Revenue change (TTM)
20.01%
Earnings per share change (TTM)
-757.70%
3-year revenue growth (CAGR)
15.62%
10-year revenue growth (CAGR)
17.09%
3-year earnings per share growth (CAGR)
76.85%
10-year earnings per share growth (CAGR)
31.01%
3-year dividend per share growth (CAGR)
-37.00%
10-year dividend per share growth (CAGR)
-11.34%
What the Analysts think about Simulations Plus
Analyst ratings (Buy, Hold, Sell) for Simulations Plus stock.
Bulls say / Bears say
Services revenue rose 17% year-over-year to $7.7 million in Q3 2025, outpacing 6% software growth and showing diversification and momentum in higher-growth, high-margin service offerings (Nasdaq).
Adjusted EBITDA margin expanded to 37% of total revenue in Q3 2025, up from 30% a year earlier, reflecting improved operational leverage and cost control (Investing.com).
Simulations Plus reaffirmed strong fiscal 2025 guidance, projecting revenue of $76–$80 million (9–14% growth) and adjusted EPS of $0.93–$1.06, signaling management's confidence in navigating current market headwinds (Nasdaq).
Simulations Plus recorded a one-time non-cash impairment charge of $77.2 million in Q3 2025, resulting in a GAAP net loss of $67.3 million, raising concerns about the valuation and performance of its acquired assets (Nasdaq).
The company cut its full-year fiscal 2025 revenue guidance by about 15%, lowering it from $90–$93 million to $76–$80 million, signaling weaker-than-expected demand and macro uncertainty among its biopharma clients (Nasdaq).
Management pointed to cautious client spending, project delays, and the cancellation of a services client, all of which slowed bookings and pressured near-term revenue visibility, underscoring potential volatility in its services pipeline (Nasdaq).
Data summarised monthly by Lightyear AI. Last updated on 16 Oct 2025.
Simulations Plus Financial Performance
Revenues and expenses
Simulations Plus Earnings Performance
Company profitability
Simulations Plus News
AllArticlesVideos
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation – SLP
Business Wire2 days ago
Simulations Plus to Participate in Upcoming Investor Conferences
Business Wire2 months ago
SLP BREAKING NEWS: Simulations Plus, Inc. Stock Significantly Declines After Impairment Charge and Auditor Departure -- Investors Urged to Contact BFA Law
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Simulations Plus stock?
Simulations Plus (SLP) has a market cap of $310M as of October 19, 2025.
What is the P/E ratio for Simulations Plus stock?
The price to earnings (P/E) ratio for Simulations Plus (SLP) stock is 0 as of October 19, 2025.
Does Simulations Plus stock pay dividends?
No, Simulations Plus (SLP) stock does not pay dividends to its shareholders as of October 19, 2025.
When is the next Simulations Plus dividend payment date?
Simulations Plus (SLP) stock does not pay dividends to its shareholders.
What is the beta indicator for Simulations Plus?
Simulations Plus (SLP) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.